Why Do Some Recovered Peripartum Cardiomyopathy Mothers Experience Heart Failure With a Subsequent Pregnancy?

被引:18
|
作者
Fett J.D. [1 ,2 ,4 ]
Shah T.P. [3 ]
McNamara D.M. [1 ]
机构
[1] Investigations of Pregnancy Associated Cardiomyopathy (IPAC), Peripartum Cardiomyopathy Network of North America (PCN), Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
[2] Department of Adult Medicine, Hospital Albert Schweitzer, Deschapelles
[3] Baylor College of Medicine, Houston, TX
[4] 2331 Mt. Hood Court SE, Lacey, 98503, WA
关键词
Biomarkers; Echocardiography; Heart failure; Outcomes; Peripartum cardiomyopathy; PPCM; Subsequent pregnancy;
D O I
10.1007/s11936-014-0354-x
中图分类号
学科分类号
摘要
After concerns about survival and recovery from peripartum cardiomyopathy (PPCM), the question commonly asked is, “Is it safe to have another pregnancy?” While important advances have been made in the past decade in the recognition and treatment of PPCM, we still do not know why some apparently recovered PPCM mothers have a relapse of heart failure in a subsequent pregnancy. Knowing that some risk for relapse is always present, careful monitoring of the post-PPCM pregnancy is currently the best way to enable earlier diagnosis with institution of effective evidence-based treatment. In that situation it is reassuring to observe that when a subsequent pregnancy begins with recovered left ventricular systolic function to echocardiographic ejection fraction ≥0.50, even with relapse, the response to treatment is good with much more favorable outcomes. On the other hand, beginning the subsequent pregnancy with echocardiographic ejection fraction <0.50 greatly increases the risk for less favorable outcomes. This article summarizes the current state of knowledge; addresses the important questions facing patients, their families, and caregivers; and identifies the need for a prospective multi-center study of women with post-PPCM pregnancies. The reality is that an estimated 10 % to 20 % of apparently recovered PPCM mothers are going to relapse in a post-PPCM pregnancy; but we do not yet know why. Nevertheless, the lowest risk for relapse is experienced by those who (1) recover to left ventricular ejection fraction 0.55 prior to another pregnancy; (2) have no deterioration of left ventricular ejection fraction after phasing out angiotensin-converting enzyme inhibitor/angiotensin-receptor blocker treatment following recovery; and perhaps, (3) demonstrate adequate contractile reserve on exercise echocardiography. © 2014, Springer Science+Business Media New York.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Outcomes of peripartum cardiomyopathy in the current era of heart failure management
    Tajjaj, JA
    Mirza, S
    Rayburn, BK
    Pinderski, LJ
    Benza, RL
    Foley, BA
    Pamboukian, S
    Bourge, RC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 205A - 205A
  • [42] Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience
    Bouabdallaoui, Nadia
    Demondion, Pierre
    Marechaux, Sylvestre
    Varnous, Shaida
    Lebreton, Guillaume
    Mouquet, Frederic
    Leprince, Pascal
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2018, 110 (02) : 181 - 187
  • [43] Recovery from severe heart failure following peripartum cardiomyopathy
    Fett, James D.
    Sannon, Herriot
    Thelisma, Emmeline
    Sprunger, Therese
    Suresh, Venkita
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 104 (02) : 125 - 127
  • [44] A tricky case of rapid ejection fraction improvement in patient with preeclampsia and peripartum cardiomyopathy complicated by subsequent heart failure readmissions
    Bondari, S.
    Soloveva, A.
    Teterina, M.
    Babaeva, L.
    Meray, I.
    Safarova, A.
    Kobalava, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 172 - 172
  • [45] Sudden Cardiac Death is Still a Risk for Some Peripartum Cardiomyopathy Mothers Reply
    Saltzberg, Mitchell T.
    Symkiewicz, Steven
    Bianco, Nicole
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (03) : 262 - 263
  • [46] Pre-Pregnancy Body Mass Index and Risk of Peripartum Cardiomyopathy and Heart Failure in the Years Following Delivery
    Mints, Yuliya
    Lyass, Asya
    Schmiegelow, Michelle D.
    Schou, Morten
    Gislason, Gunnar H.
    Christiansen, Mia N.
    Kober, Lars
    Torp-Pedersen, Christian
    Andersson, Charlotte
    CIRCULATION, 2020, 142
  • [47] Peripartum Cardiomyopathy and Pregnancy-Associated Heart Failure with Preserved Ejection Fraction: More Similar Than Different
    Rich, Michael W.
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (02) : 157 - 158
  • [48] Prolactin inhibition improves clinical outcome in peripartum cardiomyopathy patients presenting with subsequent pregnancy
    Forster, O.
    Hilfiker-Kleiner, D.
    Ansari, A. A.
    Sundstrom, J. B.
    Tshani, W.
    Yip, A.
    Becker, A.
    Sliwa, K.
    CIRCULATION, 2008, 118 (12) : E245 - E245
  • [49] How can we counsel patients desiring subsequent pregnancy after peripartum cardiomyopathy?
    Agboola, Olayinka
    Sharma, Garima
    EUROPEAN HEART JOURNAL, 2025, 46 (11) : 1041 - 1043
  • [50] Effect of subsequent pregnancy in patients with documented peripartum cardiomyopathy - a prospective echocardiographic and cytokine evaluation
    Sliwa, K
    Zhanje, F
    Kachope, J
    Essop, R
    EUROPEAN HEART JOURNAL, 2002, 23 : 450 - 450